Rika Fujii

1.6k total citations
27 papers, 637 citations indexed

About

Rika Fujii is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Rika Fujii has authored 27 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Rika Fujii's work include bioluminescence and chemiluminescence research (6 papers), CAR-T cell therapy research (4 papers) and Advanced Fluorescence Microscopy Techniques (4 papers). Rika Fujii is often cited by papers focused on bioluminescence and chemiluminescence research (6 papers), CAR-T cell therapy research (4 papers) and Advanced Fluorescence Microscopy Techniques (4 papers). Rika Fujii collaborates with scholars based in Japan, United States and China. Rika Fujii's co-authors include Jeffrey Schlom, James W. Hodge, Kazumi Matsuoka, Kwong Y. Tsang, Caroline Jochéms, Sarah R. Tritsch, Michelle R. Padget, Hiromitsu Maeda, Eitan Friedman and Christopher R. Heery and has published in prestigious journals such as Chemical Communications, Scientific Reports and Journal of neurosurgery.

In The Last Decade

Rika Fujii

25 papers receiving 617 citations

Peers

Rika Fujii

ONCOL

IMMUN

PRM

OCEAN

Michelle L. Dean Canada

Wesley D. Frey United States

Guoping Deng China

Anne Etienne France

A. Fried Israel

Shufang Zhang China

Harald Hauser Germany

Zhang Cl China

Kaname Yamamoto Japan

Benjamin D. Williams United States

Michelle L. Dean Canada

Rika Fujii

526 ×1.8

ONCOL

88 ×0.3

IMMUN

307 ×2.2

267 ×3.1

PRM

22 ×0.4

OCEAN

Citations per year, relative to Rika Fujii Rika Fujii (= 1×) peers Michelle L. Dean

Countries citing papers authored by Rika Fujii

Since Specialization

Citations

This map shows the geographic impact of Rika Fujii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rika Fujii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rika Fujii more than expected).

Fields of papers citing papers by Rika Fujii

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rika Fujii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rika Fujii. The network helps show where Rika Fujii may publish in the future.

Co-authorship network of co-authors of Rika Fujii

This figure shows the co-authorship network connecting the top 25 collaborators of Rika Fujii. A scholar is included among the top collaborators of Rika Fujii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rika Fujii. Rika Fujii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kadota, Tomohiro, Rika Fujii, Shohei Koyama, et al.. (2025). A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901). Gastric Cancer. 28(4). 718–724. 1 indexed citations

Kiyama, Masahiro, et al.. (2021). Color-tunable bioluminescence imaging portfolio for cell imaging. Scientific Reports. 11(1). 2219–2219. 20 indexed citations

Kim, Sung Bae, Rika Fujii, & Ramasamy Paulmurugan. (2021). Ligand-Activatable BRET9 Probes for Imaging Molecular Events in Living Mammalian Cells. Methods in molecular biology. 2274. 261–270. 1 indexed citations

Fabian, Kellsye P., Anthony S. Malamas, Michelle R. Padget, et al.. (2020). Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable. Cancer Immunology Research. 9(2). 239–252. 11 indexed citations

Kim, Sung Bae, Sharon S. Hori, Uday Kumar Sukumar, et al.. (2020). Highly sensitive eight-channel light sensing system for biomedical applications. Photochemical & Photobiological Sciences. 19(4). 524–529. 3 indexed citations

Kim, Sung Bae, Rika Fujii, Ryo Nishihara, et al.. (2019). Molecular Imaging of Retinoic Acids in Live Cells Using Single-Chain Bioluminescence Probes. ACS Combinatorial Science. 21(6). 473–481. 4 indexed citations

Kim, Sung Bae, Ryo Nishihara, Rika Fujii, et al.. (2018). In vitro Determination of Rapamycin-triggered FKBP-FRB Interactions Using a Molecular Tension Probe. Analytical Sciences. 35(1). 71–78. 6 indexed citations

Fujii, Rika, Caroline Jochéms, Sarah R. Tritsch, et al.. (2018). An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression. Cancer Immunology Immunotherapy. 67(4). 675–689. 57 indexed citations

Fujii, Rika, Jeffrey Schlom, & James W. Hodge. (2017). A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab. Journal of neurosurgery. 128(5). 1419–1427. 26 indexed citations

10.

Okano, Yoshiyuki, Hiroki Fujimoto, Toshiaki Watanabe, et al.. (2016). Nutritional status of patients with phenylketonuria in Japan. Molecular Genetics and Metabolism Reports. 8. 103–110. 16 indexed citations

11.

Jochéms, Caroline, James W. Hodge, Massimo Fantini, et al.. (2016). An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele. Oncotarget. 7(52). 86359–86373. 150 indexed citations

12.

Fujii, Rika, Eitan Friedman, Jacob Richards, et al.. (2016). Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab. Oncotarget. 7(23). 33498–33511. 84 indexed citations

13.

Kim, Sung Bae & Rika Fujii. (2016). How to Fabricate Functional Artificial Luciferases for Bioassays. Methods in molecular biology. 1461. 43–53. 1 indexed citations

14.

Fujii, Rika, Toru Hanamura, Takashi Suzuki, et al.. (2014). Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma. The Journal of Steroid Biochemistry and Molecular Biology. 144. 513–522. 48 indexed citations

15.

Maeda, Hiromitsu, Takashi Hashimoto, Rika Fujii, & Masahiro Hasegawa. (2009). Dipyrrin Zn<SUP>II</SUP> Complexes with Functional Aryl Groups: Formation, Characterization, and Structures in the Solid State. Journal of Nanoscience and Nanotechnology. 9(1). 240–248. 17 indexed citations

16.

Maeda, Hiromitsu, et al.. (2007). Micro‐ and Nanometer‐Scale Porous, Fibrous, and Sheet Architectures Constructed by Supramolecular Assemblies of Dipyrrolyldiketones. Chemistry - An Asian Journal. 2(3). 350–357. 30 indexed citations

17.

Matsuoka, Kazumi, Rika Fujii, Masao Hayashi, & Zhaohui Wang. (2006). Recent occurrence of toxic <i>Gymnodinium catenatum</i> Graham (Gymnodiniales, Dinophyceae) in coastal sediments of West Japan. Paleontological Research. 10(2). 117–125. 7 indexed citations

18.

Fujii, Rika, et al.. (1997). Pulmonary embolism after laparoscopy-assisted colectomy. Journal of Anesthesia. 11(1). 68–70. 3 indexed citations

19.

Fujii, Rika, et al.. (1997). Pulmonary embolism after laparoscopy-assisted colectomy. Journal of Anesthesia. 11(1). 1 indexed citations

20.

Yamamoto, K., et al.. (1996). [The production of high sensitive anti-myeloperoxidase monoclonal antibodies and their sensitivity and specificity].. PubMed. 44(7). 687–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact